Gianmario Usai

Evaluation of antibody response to BNT162b2 mRNA COVID-19 vaccine in patients affected by immune-mediated inflammatory diseases up to 5 months after vaccination

F. Meloni, M. Carta, M. Campagna, 2021, Clinical and Experimental Medicine.

Evaluation of antibody response to BNT162b2 mRNA COVID-19 vaccine in patients affected by immune-mediated inflammatory diseases up to 5 months after vaccination

F. Meloni, M. Carta, M. Campagna, 2021, Clinical and Experimental Medicine.

Evaluation of Antibody Response to Heterologous Prime–Boost Vaccination with ChAdOx1 nCoV-19 and BNT162b2: An Observational Study

F. Meloni, M. Carta, M. Campagna, 2021, Vaccines.